Molecular Testing in Metastatic Gastric/GEJ Cancer

2 Views
administrator
administrator
06/30/23

David Ilson, MD, PhD, reflects on the role of molecular testing in the treatment of metastatic gastric/gastroesophageal junction cancer and its impact on prognosis and clinical decision making.

Show more

0 Comments Sort By

No comments found

Facebook Comments

Up next